BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34267520)

  • 1. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.
    Sil BK; Jamiruddin MR; Haq MA; Khondoker MU; Jahan N; Khandker SS; Ali T; Oishee MJ; Kaitsuka T; Mie M; Tomizawa K; Kobatake E; Haque M; Adnan N
    Int J Nanomedicine; 2021; 16():4739-4753. PubMed ID: 34267520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
    Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
    Front Public Health; 2020; 8():620222. PubMed ID: 33681115
    [No Abstract]   [Full Text] [Related]  

  • 3. Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
    Barreira GA; Santos EHD; Pereira MFB; Rodrigues KA; Rocha MC; Kanunfre KA; Marques HHS; Okay TS; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Costa Reis AGA; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
    Rev Inst Med Trop Sao Paulo; 2022; 64():e49. PubMed ID: 35858039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2.
    Sil BK; Jahan N; Haq MA; Oishee MJ; Ali T; Khandker SS; Kobatake E; Mie M; Khondoker MU; Jamiruddin MR; Adnan N
    PLoS One; 2021; 16(2):e0246346. PubMed ID: 33529223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
    Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
    J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay.
    Ahmadi A; Mirzaeizadeh Z; Omidfar K
    Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):210-218. PubMed ID: 34678096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients.
    El-Shershaby A; Hussein N; Ali E; El-Hakim A; Tabll A; Shaheen M; Ali I; Elshall M; Shahein Y
    J Immunoassay Immunochem; 2023 Jul; 44(4):338-359. PubMed ID: 37319429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of SARS-CoV-2 IgG assays in India.
    Chaudhuri S; Thiruvengadam R; Chattopadhyay S; Mehdi F; Kshetrapal P; Shrivastava T; Desiraju BK; Batra G; Kang G; Bhatnagar S;
    J Clin Virol; 2020 Oct; 131():104609. PubMed ID: 32866811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array.
    Fisher M; Levy H; Fatelevich E; Afrimov Y; Ben-Shmuel A; Rosenfeld R; Noy-Porat T; Glinert I; Sittner A; Biber A; Belkin A; Bar-David E; Puni R; Levy I; Mazor O; Weiss S; Mechaly A
    Microbiol Spectr; 2021 Oct; 9(2):e0087021. PubMed ID: 34612689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.
    Emmerich P; Murawski C; Ehmen C; von Possel R; Pekarek N; Oestereich L; Duraffour S; Pahlmann M; Struck N; Eibach D; Krumkamp R; Amuasi J; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Kann S; May J; Tannich E; Deschermeier C
    Trop Med Int Health; 2021 Jun; 26(6):621-631. PubMed ID: 33666297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    Tozetto-Mendoza TR; Kanunfre KA; Vilas-Boas LS; Sanchez Espinoza EP; Paião HGO; Rocha MC; de Paula AV; de Oliveira MS; Zampelli DB; Vieira JM; Buss L; Costa SF; Sabino EC; Witkin SS; Okay TS; Mendes-Correa MC
    J Virol Methods; 2021 Apr; 290():114064. PubMed ID: 33453299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study.
    Plebani M; Parčina M; Bechri I; Zehender G; Terkeš V; Abdel Hafith B; Antinori S; Pillet S; Gonzalo S; Hoerauf A; Lai A; Morović M; Bourlet T; Torre A; Pozzetto B; Galli M
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33218990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals.
    da Costa HHM; Silva VO; Amorim GC; Guereschi MG; Sergio LM; Gomes CHR; Hong MA; de Oliveira EL; Brígido LFM; Lindoso JAL; Prudencio CR
    J Immunol Methods; 2024 Jul; 530():113683. PubMed ID: 38759864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
    Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.
    Salem R; Elshamy AM; Kamel N; Younes S; Marie OM; Waly FR; El-Kholy AA; Elmenofy W
    Biotechnol Lett; 2022 Dec; 44(12):1507-1517. PubMed ID: 36319880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.